
Read more VitroScan Technology
Fast and accurate ex vivo 3D micro tumor testing to support better informed treatment decisions & improve patient stratification for clinical trials.
Read more
Read more Predictive Testing Solutions
VitroScan runs efficient and clinically relevant projects to expose the unique strength of novel drugs and stage successful clinical validation. Outperform the competition by accelerated clinical development.
Read more
Read more Personalized Treatment
In VitroScan's ongoing clinical trial program predictive algorithms are established and validated for multiple drugs and cancer types.
Read moreNews & Events

Read more Interpretation of patient-specific ex vivo immunotherapy response for ovarian cancer - VitroScan presents @ the AACR-NCI-EORTC meeting 2023
14 October 2023
At the AACR-NCI-EORTC International Conference on Molecular Targets and Cancer Therapeutics October 11-15, 2023, in Boston, Willemijn Vader presented our most recent results on 'Interpretation of patient-specific ex vivo immunotherapy response for ovarian cance
Read more
Read more InCephalo AG, University of Basel and VitroScan win Eurostars grant
9 October 2023
InCephalo AG, University of Basel and VitroScan receive competitive Eurostars grant (€2,3M) to accelerate the development of promising new drugs for Glioblastoma patients - CLEIO
Read more
Read more KWF awarded EXPACT project on Pancreatic Cancer
5 September 2023
Pioneering Pancreatic Cancer Research Collaboration for starting KWF-Public Private Partnership project We are delighted to announce the commencement of a unique research collaboration among Leiden University Medical Center, VitroScan, and the Centre for Human Drug Research. This collaboration was recently awarded a KWF-Public Private Partnership grant by the KWF-kankerfonds (KWF Kankerbestrijding - Dutch Cancer Society).
Read more